OREGA Biotech
PrivateLast Round
Grant
Oct 5, 2012
Total Funding Raised
$6.4M
Company Overview
OREGA Biotech is a biotechnology company that specializes in the discovery and development of first-in-class monoclonal antibodies for cancer immunotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OREGA Biotech Comparables
Compare OREGA Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomunex Pharmaceuticals | 85% | |
| Alderaan Biotechnology | 82% | |
| Netris Pharma | 82% |
OREGA Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 5, 2012 | ||||
| Seed | Nov 22, 2010 |
OREGA Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Octalfa | Seed, Series B |
| Agence Nationale de la Recherche | Grant |
| Inserm Transfert | Seed |
| Turenne Groupe | Series B |
| Kreaxi | Seed, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 8, 2025
Monthly visitors increased 88% MoM.
- May 2, 2025
Monthly visitors grew 80% MoM, from 360 to 649.
OREGA Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OREGA Biotech's valuation, stock price, and market status.
Is OREGA Biotech a public or private company?
OREGA Biotech is a private company.
What is the current stock price of OREGA Biotech?
OREGA Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is OREGA Biotech worth (valuation)?
Valuation information for OREGA Biotech is not publicly available.
Can I buy OREGA Biotech stock?
OREGA Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OREGA Biotech's last funding round?
OREGA Biotech's most recent funding round was Grant on October 5, 2012.
Who are the main investors in OREGA Biotech?
Key investors in OREGA Biotech include Agence Nationale de la Recherche.
Will OREGA Biotech IPO soon?
No public IPO plans have been announced for OREGA Biotech.
How can I track OREGA Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OREGA Biotech's secondary market activity and sign up for updates.